2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions

View by Date

Abstract Number: 153

Utility of Ultrasound Synovitis Assessment As a Predictor of Flares in Clinically Inactive Joints
Abstract Number: 154

Clinical Features of Fibromyalgia in Patients with Rheumatoid Arthritis Predict Lower Power Doppler Scores on Ultrasound
Abstract Number: 155

Absence of Clinical and Ultrasound Activity of Hand and Foot: Is That Possible?: Experience in an Argentinian Rheumatoid Arthritis Cohort
Abstract Number: 156

Usefulness of the Stricter Remission Criteria for Assessing the Absence of Subclinical Activity in Rheumatoid Arthritis
Abstract Number: 157

Agreement Between DAS28, ACR/EULAR, SDAI, CDAI and Ultrasound Remission in Patients with Rheumatoid Arthritis Receiving Biological Treatment in Routine Care
Abstract Number: 158

Ultrasound Score of Dominant Hand in Patients with Rheumatoid Arthritis Correlates with DAS28CRP, CDAI and SDAI but Not RAPID-3
Abstract Number: 159

Power Doppler Continuous Quantitative Assessment Techniques Is Faster Than Semiquantitative Assesment in Identification of Therapeutic Response
Abstract Number: 160

When Compared with a Computerized System Both Experienced and in-Training Sonographers Have Difficulties to Select the Best Doppler Image from a Cine-Loop
Abstract Number: 161

Ultrasonographic Evaluation of Rheumatoid Hand: Hand Disability and Disease Activity Correlation
Abstract Number: 162

Ultrasonography Versus Clinical Examination in Early DMARD-Naïve Rheumatoid Arthritis – a Comparative Study of Synovitis on the Individual Joint Level
Abstract Number: 163

Ultrasonographic Assessment Covers Clinical Examination in the Localization of Ankle Pathology in Rheumatoid Arthritis
Abstract Number: 164

Subclinical Ankle Involvement in Rheumatoid Arthritis. a Multicentre Ultrasound Study
Abstract Number: 165

Validation of a New Ultrasound Criteria for Subclinical Synovitis in Chronic Inflammatory Polyarthritis
Abstract Number: 166

Validity and Sensitivity to Change of the Semi-Quantitative Omeract Ultrasound Scoring System for Tenosynovitis in Patients with Rheumatoid Arthritis
Abstract Number: 167

Negative Gaenslen’s (Squeeze) Test Has a High Negative Predictive Value for Significant Ultrasonographic Metatarsophalangeal Involvement in Early Arthritis

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].